Park, M <br/><br/>
Enterostatin inhibition of angiogenesis: possible role of pAMPK and vascular endothelial growth factor A (VEGF-A).  [electronic resource] 

 -  International journal of obesity (2005)  Jun 2008 
 - 922-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5497 
<br/><br/><label>Standard No.: </label>10.1038/ijo.2008.16  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenylate Kinase--antagonists & inhibitors<br/>Aminoimidazole Carboxamide--analogs & derivatives<br/>Angiogenesis Inhibitors--pharmacology<br/>Blotting, Western<br/>Cell Line<br/>Colipases--pharmacology<br/>Dose-Response Relationship, Drug<br/>Enzyme Precursors--pharmacology<br/>Gene Expression--drug effects<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>In Vitro Techniques<br/>Neovascularization, Pathologic--pathology<br/>Oligonucleotide Array Sequence Analysis<br/>RNA, Messenger--analysis<br/>Ribonucleotides--pharmacology<br/>Subcutaneous Fat, Abdominal--blood supply<br/>Umbilical Veins--blood supply<br/>Vascular Endothelial Growth Factor A--genetics